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Effect of Preinjury Use of Antiplatelet Agents in Patients with Isolated 
Traumatic Brain Injury
Lehigh Valley Health Network, Allentown, Pennsylvania and Medical College of Wisconsin, Milwaukee, Wisconsin
Background
Danielle Cheeseman MD, David Milia MD, David Kashmer MD, Farheen Hussain MS, John Hong MD, Robert Barraco MD.  Division of Trauma and Critical Care
Results
The incidence of traumatic brain injury (TBI) has remained constant 
over the past decade, but the use of antiplatelet (AP) agents 
has steadily increased, particularly in the elderly population.  An 
increasing number of patients admitted with isolated TBI are on 
AP therapy at the time of trauma.  Few studies have examined the 
effects of preinjury AP use on outcome following isolated TBI. 
•  438 patients with isolated TBI, 48% taking AP or warfarin. 
•  No significant difference in mortality between AP & Neither 
groups.
Conclusions
•  A large number of patients with isolated TBI take AP agents or 
warfarin prior to injury.
•  Patients with isolated TBI on AP agents or warfarin are older than 
TBI patients not taking AP or warfarin.
•  Patients who received platelet transfusions have worse outcomes 
compared to those who did not.
Methods
A retrospective review of our institutional trauma database 
was conducted from January 2007 to June 2008.  All patients 
admitted with the diagnosis of isolated TBI were evaluated.  Data 
on demographics, admission GCS, in-hospital GCS, ISS, head 
AIS, platelet count, PT, PTT, INR, use and type of antiplatelet 
or anticoagulation medication, progression of TBI, need for 
neurosurgical intervention, in-hospital mortality, discharge 
disposition, and readmission within 30 days were collected.  A 
multiple regression analysis was performed. Clinical Characteristic AP Neither P
     Intubated on Admission 3 27 0.001
     Progression on TBI 15 20 NS
     Need for Surgical Intervention 27 31 NS
     Mortality 9 26 NS
     Platelet Transfusion 10 9 NS
     Readmission within 30 days 25 16 O.001
Clinical Characteristic AP Only Warfarin Only
AP & 
Warfarin Neither
      Age (years) 76.1 77.1 78.3 56.1









Platelet Transfusion Yes No P
     INR 1.27 1.14 NS
     Platelets 195 256 0.02
     GCS 11.7 13.3 NS
     AIS 4.5 4 0.01
     LOS 4 3 NS
     ICU LOS 2 1 0.01
     Progression of TBI 6 29 0.001
     Need for Surgical Intervention 8 50 0.001
     Mortality 5 30 0.01
     Antiplatelet Use 10 124 NS
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